Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials
Author:
Affiliation:
1. Albany College of Pharmacy and Health Sciences, Albany, New York, USA
2. Covance Market Access Services Inc., Gaithersburg, Maryland, USA
3. Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania, USA
Abstract
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology
Link
http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa145/33125108/ofaa145.pdf
Reference26 articles.
1. Efficacy and safety of IV-to-oral lefamulin, a pleuromutilin antibiotic, for treatment of community-acquired bacterial pneumonia: the phase 3 LEAP 1 trial;File;Clin Infect Dis,2019
2. Lefamulin: a promising new pleuromutilin antibiotic in the pipeline;Dillon;Expert Rev Anti Infect Ther,2019
3. Lefamulin: review of a promising novel pleuromutilin antibiotic;Veve;Pharmacotherapy,2018
4. Oral lefamulin vs moxifloxacin for early clinical response among adults with community-acquired bacterial pneumonia: the LEAP 2 randomized clinical trial;Alexander;JAMA
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical use of lefamulin: A first‐in‐class semisynthetic pleuromutilin antibiotic;Journal of Internal Medicine;2021-10-09
2. Clinical Pharmacokinetics and Pharmacodynamics of Lefamulin;Clinical Pharmacokinetics;2021-07-13
3. Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial;The Journal of Emergency Medicine;2021-06
4. Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities;BMC Pulmonary Medicine;2021-05-08
5. Cprp—An Unusual, Repetitive Protein Which Impacts Pleuromutilin Biosynthesis in the Basidiomycete Clitopilus passeckerianus;Frontiers in Fungal Biology;2021-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3